115 related articles for article (PubMed ID: 22162109)
1. Molecular recognition at the active site of factor Xa: cation-π interactions, stacking on planar peptide surfaces, and replacement of structural water.
Salonen LM; Holland MC; Kaib PS; Haap W; Benz J; Mary JL; Kuster O; Schweizer WB; Banner DW; Diederich F
Chemistry; 2012 Jan; 18(1):213-22. PubMed ID: 22162109
[TBL] [Abstract][Full Text] [Related]
2. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
[TBL] [Abstract][Full Text] [Related]
3. Quantification of cation-pi interactions in protein-ligand complexes: crystal-structure analysis of Factor Xa bound to a quaternary ammonium ion ligand.
Schärer K; Morgenthaler M; Paulini R; Obst-Sander U; Banner DW; Schlatter D; Benz J; Stihle M; Diederich F
Angew Chem Int Ed Engl; 2005 Jul; 44(28):4400-4. PubMed ID: 15952226
[No Abstract] [Full Text] [Related]
4. Profiling the structural determinants for the selectivity of representative factor-Xa and thrombin inhibitors using combined ligand-based and structure-based approaches.
Bhunia SS; Roy KK; Saxena AK
J Chem Inf Model; 2011 Aug; 51(8):1966-85. PubMed ID: 21761917
[TBL] [Abstract][Full Text] [Related]
5. Urethanyl-3-amidinophenylalanine derivatives as inhibitors of factor Xa. X-ray crystal structure of a trypsin/inhibitor complex and modeling studies.
Sperl S; Bergner A; Stürzebecher J; Magdolen V; Bode W; Moroder L
Biol Chem; 2000 Apr; 381(4):321-9. PubMed ID: 10839461
[TBL] [Abstract][Full Text] [Related]
6. Co-crystal structure and inhibition of factor Xa by PD0313052 identifies structurally stabilized active site residues of factor Xa and prothrombinase.
Gould WR; Cladera E; Harris MS; Zhang E; Narasimhan L; Thorn JM; Leadley RJ
Biochemistry; 2005 Jul; 44(26):9280-9. PubMed ID: 15981994
[TBL] [Abstract][Full Text] [Related]
7. β-D-glucosyl conjugates of highly potent inhibitors of blood coagulation factor Xa bearing 2-chorothiophene as a P1 motif.
Lopopolo G; de Candia M; Panza L; Romano MR; Lograno MD; Campagna F; Altomare C
ChemMedChem; 2012 Sep; 7(9):1669-77. PubMed ID: 22851501
[TBL] [Abstract][Full Text] [Related]
8. (R)-3-Amidinophenylalanine-derived inhibitors of factor Xa with a novel active-site binding mode.
Mueller MM; Sperl S; Stürzebecher J; Bode W; Moroder L
Biol Chem; 2002; 383(7-8):1185-91. PubMed ID: 12437104
[TBL] [Abstract][Full Text] [Related]
9. Structural requirements for factor Xa inhibition by 3-oxybenzamides with neutral P1 substituents: combining X-ray crystallography, 3D-QSAR, and tailored scoring functions.
Matter H; Will DW; Nazaré M; Schreuder H; Laux V; Wehner V
J Med Chem; 2005 May; 48(9):3290-312. PubMed ID: 15857135
[TBL] [Abstract][Full Text] [Related]
10. Contribution of explicit solvent effects to the binding affinity of small-molecule inhibitors in blood coagulation factor serine proteases.
Abel R; Salam NK; Shelley J; Farid R; Friesner RA; Sherman W
ChemMedChem; 2011 Jun; 6(6):1049-66. PubMed ID: 21506273
[TBL] [Abstract][Full Text] [Related]
11. Design and structure-activity relationships of potent and selective inhibitors of blood coagulation factor Xa.
Ewing WR; Becker MR; Manetta VE; Davis RS; Pauls HW; Mason H; Choi-Sledeski YM; Green D; Cha D; Spada AP; Cheney DL; Mason JS; Maignan S; Guilloteau JP; Brown K; Colussi D; Bentley R; Bostwick J; Kasiewski CJ; Morgan SR; Leadley RJ; Dunwiddie CT; Perrone MH; Chu V
J Med Chem; 1999 Sep; 42(18):3557-71. PubMed ID: 10479288
[TBL] [Abstract][Full Text] [Related]
12. Cation-pi interactions at the active site of factor Xa: dramatic enhancement upon stepwise N-alkylation of ammonium ions.
Salonen LM; Bucher C; Banner DW; Haap W; Mary JL; Benz J; Kuster O; Seiler P; Schweizer WB; Diederich F
Angew Chem Int Ed Engl; 2009; 48(4):811-4. PubMed ID: 19101972
[No Abstract] [Full Text] [Related]
13. Phenyltriazolinones as potent factor Xa inhibitors.
Quan ML; Pinto DJ; Rossi KA; Sheriff S; Alexander RS; Amparo E; Kish K; Knabb RM; Luettgen JM; Morin P; Smallwood A; Woerner FJ; Wexler RR
Bioorg Med Chem Lett; 2010 Feb; 20(4):1373-7. PubMed ID: 20100660
[TBL] [Abstract][Full Text] [Related]
14. Rational design and synthesis of novel, potent bis-phenylamidine carboxylate factor Xa inhibitors.
Maduskuie TP; McNamara KJ; Ru Y; Knabb RM; Stouten PF
J Med Chem; 1998 Jan; 41(1):53-62. PubMed ID: 9438022
[TBL] [Abstract][Full Text] [Related]
15. Evidence for C-Cl/C-Br...pi interactions as an important contribution to protein-ligand binding affinity.
Matter H; Nazaré M; Güssregen S; Will DW; Schreuder H; Bauer A; Urmann M; Ritter K; Wagner M; Wehner V
Angew Chem Int Ed Engl; 2009; 48(16):2911-6. PubMed ID: 19294721
[TBL] [Abstract][Full Text] [Related]
16. Understanding binding selectivity toward trypsin and factor Xa: the role of aromatic interactions.
Di Fenza A; Heine A; Koert U; Klebe G
ChemMedChem; 2007 Mar; 2(3):297-308. PubMed ID: 17191291
[TBL] [Abstract][Full Text] [Related]
17. Water molecules participate in proteinase-inhibitor interactions: crystal structures of Leu18, Ala18, and Gly18 variants of turkey ovomucoid inhibitor third domain complexed with Streptomyces griseus proteinase B.
Huang K; Lu W; Anderson S; Laskowski M; James MN
Protein Sci; 1995 Oct; 4(10):1985-97. PubMed ID: 8535235
[TBL] [Abstract][Full Text] [Related]
18. Unexpected binding mode of tick anticoagulant peptide complexed to bovine factor Xa.
Wei A; Alexander RS; Duke J; Ross H; Rosenfeld SA; Chang CH
J Mol Biol; 1998; 283(1):147-54. PubMed ID: 9761680
[TBL] [Abstract][Full Text] [Related]
19. Structure based drug design: development of potent and selective factor IXa (FIXa) inhibitors.
Wang S; Beck R; Burd A; Blench T; Marlin F; Ayele T; Buxton S; Dagostin C; Malic M; Joshi R; Barry J; Sajad M; Cheung C; Shaikh S; Chahwala S; Chander C; Baumgartner C; Holthoff HP; Murray E; Blackney M; Giddings A
J Med Chem; 2010 Feb; 53(4):1473-82. PubMed ID: 20121197
[TBL] [Abstract][Full Text] [Related]
20. Probing the subpockets of factor Xa reveals two binding modes for inhibitors based on a 2-carboxyindole scaffold: a study combining structure-activity relationship and X-ray crystallography.
Nazaré M; Will DW; Matter H; Schreuder H; Ritter K; Urmann M; Essrich M; Bauer A; Wagner M; Czech J; Lorenz M; Laux V; Wehner V
J Med Chem; 2005 Jul; 48(14):4511-25. PubMed ID: 15999990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
